AIM ImmunoTech (AIM) executive compensation, 2026 proxy

Thomas K Equels, CEO & President, was paid $822,983 in 2025, down 24% from $1.1M the year before.

Filed
September 30, 2026
Annual meeting
November 17, 2026
Pay year
2025
Named executives
3
CEO total pay
$822,983-24% vs prior year
2025 CEO salary
$716,667Includes voluntarily deferred salary
Equels other compensation
$106,316Insurance, car and 401(k)
2025 Rodino total
$457,014
2025 Dickey total
$108,420
2024 CEO total
$1,089,725

How Equels was paid

$822,983 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary87%All other compensation13%

Named executive officers

ExecutiveTotal
Thomas K EquelsCEO & President$822,983
Robert Dickey IVCFO$108,420
Peter RodinoCOO, Exec. Director for Governmental Relations, General Counsel and Secretary$457,014

What changed and why

  • $823K2025 CEO total compensation was $822,983, down from $1,089,725 in 2024.
  • $142KApproximately $141,667 of Mr. Equels’s salary was voluntarily deferred because of Company cash-flow concerns.
  • 2025 bonuses were waived by all named executives to conserve cash.
  • No stock was issued as payroll in 2025, and 2025 options were waived.
  • $41,0732025 All Other Compensation included $41,073 insurance and $16,245 in 401(k) matching for Mr. Equels.

Other AIM ImmunoTech proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.